Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martin B Whyte
Is High-Density Lipoprotein a Modifiable Treatment Target or Just a Biomarker for Cardiovascular Disease?
JRSM Cardiovascular Disease
Related publications
Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
High-Density Lipoprotein-Associated Paraoxonase 1: A Possible Prognostic Biomarker for Heart Failure?
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
High-Density Lipoprotein Cholesterol and Cardiovascular Disease. Four Prospective American Studies
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Association of Total Cholesterol, Low-Density Lipoprotein Cholesterol, and Non-High-Density Lipoprotein Cholesterol With Atherosclerotic Cardiovascular Disease and Cancer in a Chinese Male Population
International Journal of Cancer
Cancer Research
Oncology
High Density Lipoprotein (Α Lipoprotein) in Ischemic Heart Disease
The Journal of Japan Atherosclerosis Society
8OHdG Is Not a Biomarker for Huntington Disease State or Progression
Neurology
Neurology
High Density Lipoproteins-Based Therapies for Cardiovascular Disease
Journal of Cardiovascular Disease Research
Cardiovascular Medicine
Cardiology
Statin-Centric Versus Low-Density Lipoprotein-Centric Approach for Atherosclerotic Cardiovascular Disease Prevention: A Singapore Perspective
Singapore Medical Journal
Medicine
The Role of Niacin in Raising High-Density Lipoprotein Cholesterol to Reduce Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease and Optimally Treated Low-Density Lipoprotein Cholesterol
American Heart Journal
Cardiovascular Medicine
Cardiology
